My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Patient Enrollment

Recent news which mentions Patient Enrollment

Axsome Therapeutics Commences Late-Stage Migraine Study
Tickers AXSM
Tags Market News AXSM Health Care
From Benzinga
Stoke Therapeutics Commences Initial-Stage Optic Nerve Disorder Study
Tickers STOK
Tags Small Cap Benzinga Biotech
From Benzinga
Annovis Shares Gain As Late-Stage Parkinson's Disease Study Takes-off
Tickers ANVS
Tags General ANVS Biotech
From Benzinga
Cue Biopharma Shares Decline Following Initial-Stage Metastatic Cancer Study Kicks-off
Tickers CUE
Tags Market News Penny Stocks Health Care
From Benzinga
BridgeBio Shares Fall As Initial-Stage Rare Metabolic Disorder Study Kicks-off
Tickers BBIO
Tags General Biotech Benzinga
From Benzinga
Palisade Bio Shares Drop Following Commencement Of Late-Stage Return Of Bowel Study
Tickers PALI
Tags Movers & Shakers Patient Enrollment Penny Stocks
From Benzinga
Anixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Study
Tickers ANIX
Tags Market News Penny Stocks Health Care
From Benzinga
Virios Therapeutics Commences Mid-Stage Long-COVID Study
Tickers VIRI
Tags Market News VIRI Patient Enrollment
From Benzinga
Avalo Therapeutics' Shares Climb Following Patient Dosing in Immunodeficiency Disorder Study
Tickers AVTX
Tags Market News Movers & Shakers Patient Enrollment
From Benzinga
Kymera Therapeutics Commences Initial-Stage Oncology Trials
Tickers KYMR
Tags General Biotech Small Cap
From Benzinga
Apellis Begins Paitent Dosing In Late-Stage Study Of Rare Kidney Disease Candidate
Tickers APLS
Tags Market News Health Care Patient Enrollment
From Benzinga
Moderna Commences Late-stage Study of Flu Vaccine Candidate
Tickers MRNA
Tags Benzinga Biotech Market News
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.